KRYSTEL JOY RONCALES: Open Payments
NPI 1215692413 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 35 payments from 16 companies in 2025. Trend: 2023 $486 · 2024 $532 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Novo Nordisk Inc | 3 | $87 |
| Calliditas Therapeutics US Inc. | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Travere Therapeutics, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $50 |
| Fresenius USA Marketing, Inc. | 2 | $38 |
| Vifor Pharma, Inc. | 1 | $35 |
Products named: TARPEYO, Rivfloza, Kerendia, JYNARQUE, LOKELMA, JARDIANCE, Fabhalta, Vanrafia.
Industry payments across CO — which companies pay providers there.
